Calprotectin vs Laktoferin: Milih Tes Tinja

Kategori
Artikel
Kesehatan Usus Interpretasi Lab Pembaruan 2026 Ramah Pasien

Kaloro tes kasebut ngerteni peradangan usus sing didorong dening neutrofil, nanging kalprotektin biasane dadi alat pemantauan kuantitatif sing luwih migunani. Asil sing bener yaiku sing ngganti keputusan klinis sabanjure—dudu sing menehi label IBD.

📖 ~11 menit 📅
📝 Diterbitake: 🩺 Ditinjau kanthi medis: ✅ Adhedhasar Bukti
⚡ Ringkesan Cepet v1.0 —
  1. Kalprotektin ing ngisor 50 µg/g biasane ngemong ing wong diwasa kanthi curiga IBS nalika ora ana fitur tandha-tandha.
  2. Laktoperin minangka protein neutrofil; akeh tes kuantitatif nggunakake kurang saka 7.25 µg/g minangka negatif, nanging wates laboratorium beda-beda.
  3. Tandha tinja dhuwur nuduhake peradangan usus, dudu diagnosis tartamtu; infeksi, NSAID, divertikulitis lan neoplasia kolorektal bisa mundhakake kalorone.
  4. Calprotectin wates saka 50–150 µg/g asring mbutuhake sampel ulang sawise 2-6 minggu tinimbang kolonoskopi langsung.
  5. Kalprotektin ndhuwur 250 µg/g mundhakake keprihatinan babagan peradangan mukosa aktif lan biasane njaluk tinjauan klinis, tes infeksi tinja utawa perencanaan endoskopi.
  6. Asil normal ndadosi penyakit radang usus gedhe (IBD) ing usus gedhe luwih cilik, nanging ora bisa ngilangi penyakit Crohn ing usus cilik kanthi andal.
  7. Pangawasan IBD nggunakake gejala plus biomarker, CRP, tandha anemia, pencitraan lan endoskopi; ora ana tandha tinja sing nuduhake radhang kanthi mandiri.
  8. gejala sing darurat kayata tinja ireng, getih katon terus-terusan, demam, nyeri abot, semaput utawa dehidrasi mbutuhake evaluasi medis sanajan ana asil tandha.

Penanda tinja endi sing kudu dipilih dhisik?

Fecal calprotectin biasane minangka tandha radhang tinja sing dipilih dhisik amarga kasedhiya akeh, kuantitatif, lan duwe peran paling kuat ing misahake penyakit radang usus sing kemungkinan saka gejala usus fungsional. Tes laktoferin feses asil minangka alternatif sing masuk akal nalika assay wis divalidasi sacara lokal, nanging pesen loro ing wiwitan arang ngganti perawatan.

Calprotectin vs lactoferrin laboratory proteins shown beside an intestinal cross-section
Gambar 1: Loro tandha tinja sing diturunake saka neutrofil sing ditampilake ing jejere lapisan usus gedhe.

Kanggo wong sing duwe tinja longgar 6 minggu, kram, lan ora ana bobot mundhut utawa pendarahan rektum, aku biasane miwiti kanthi calprotectin plus tes infeksi sing ditargetake tinimbang kolonoskopi. Asil ing ngisor 50 µg/g ndadekake inflamasi usus gedhe sing signifikan luwih cilik, dene asil sing cetha mundhak menehi alesan kanggo nelusuri luwih jero. Pedoman AGA kanggo diare banyu kronis ndhukung calprotectin utawa laktobferrin minangka tes skrining kanggo kondisi inflamasi (Smalley et al., 2019).

Pilih laktobferrin nalika layanan gastroenterologi sampeyan nggunakake kanthi konsisten, nalika laboratorium nglaporake nilai kuantitatif sing divalidasi, utawa nalika dibundel karo pemeriksaan diare infeksi. Aja milih amarga katon luwih spesifik: loro protein kasebut dilepaskan nalika neutrofil mlebu ing lumen usus. Masalah praktis yaiku apa dokter sampeyan bisa mbandhingake asil karo sampel sadurunge nggunakake assay sing padha.

Kantesti iku sawijining Analisa tes getih AI sing nempatake asil sing gegandhengan kayata hemoglobin, CRP, albumin lan indeks wesi bebarengan karo laporan tandha tinja; ora ngganti assay tinja utawa diagnosis dokter. Yen kesel ngiringi diare, a tes getih kanggo diare bisa mbantu ngidentifikasi dehidrasi, anemia, utawa ilang elektrolit sing ngganti kabutuhan mendesak.

Aturan praktis sing migunani

Gunakake siji tandha sing divalidasi dhisik, baleni tandha sing padha nalika asil bias utawa nalika ngawasi perawatan, lan gunakake tes ganda kanggo pitakonan gastroenterologi tartamtu. Ngowahi assay ing tengah-tengah tindak lanjut nggawe tren sing katon sing bisa uga gangguan laboratorium tinimbang biologi.

Apa sing dideteksi kalprotektin tinja

Calprotectin ngukur protein pengikat kalsium lan seng sing umume dilepaskan saka neutrofil ing saluran usus. Konsentrasi tinja sing luwih dhuwur nuduhake migrasi neutrofil menyang usus, sing umum ing IBD aktif nanging uga kedadeyan ing sawetara kondisi non-IBD.

Fecal calprotectin test sample tray with an immunoassay cartridge in clinical laboratory
Gambar 2: Alur kerja ekstraksi tinja kuantitatif sing digunakake kanggo pangukuran calprotectin.

Calprotectin minangka kompleks protein S100A8/S100A9, lan tetep relatif stabil ing tinja nganti pirang-pirang dina ing suhu kamar—siji alesan iku bisa digunakake kanthi apik minangka tes koleksi ing omah. Kekuwatan biologisé yaiku lokalitas: ora kaya CRP, nuduhake aktivitas seluler ing lumen usus tinimbang respon fase akut awak kabeh. CRP normal mula ora mbatalake asil calprotectin sing dhuwur.

Ing praktik diwasa, laboratorium umumé klasifikasi kurang saka 50 µg/g minangka normal lan luwih saka 150–250 µg/g minangka saya cocog karo inflamasi usus aktif. Iki minangka ambang keputusan, dudu wates biologis universal. Sawetara layanan Eropa nggunakake 100 µg/g minangka ambang rujukan, dene interval referensi pediatrik lan spesifik assay bisa beda banget.

Aku wis weruh wong umur 28 taun kanthi calprotectin 680 µg/g, CRP normal, lan pungkasane kolitis ulseratif winates ing rektum lan kolon sigmoid. Pola kasebut ora aneh: inflamasi mukosa lokal bisa aktif tanpa sinyal sistemik sing kuwat. Kita fecal calprotectin range guide explains why the laboratory’s own method and units should stay attached to every result.

Apa sing dideteksi laktoperin tinja kanthi beda

Lactoferrin detects another neutrophil-derived protein and answers nearly the same biological question as calprotectin: is there active intestinal neutrophil inflammation? It does not identify ulcerative colitis, Crohn’s disease, bacterial colitis, or another cause on its own.

Lactoferrin protein molecules near intestinal neutrophils in medical cellular illustration
Gambar 3: Lactoferrin release from neutrophils during an intestinal tissue response.

Lactoferrin is an iron-binding glycoprotein stored in neutrophil secondary granules and released during activation. A positive qualitative fecal lactoferrin test is useful because it argues against uncomplicated IBS in the right clinical setting. Quantitative assays vary: one commonly used method defines a negative value as less than 7.25 µg/g, so never apply a calprotectin cutoff to a lactoferrin report.

The evidence does not show that lactoferrin is categorically superior. In a diagnostic meta-analysis, Wang and colleagues found fecal lactoferrin had pooled sensitivity of 82% and specificity of 95% for distinguishing IBD from non-IBD controls, although accuracy estimates shift with disease prevalence and study design (Wang et al., 2015). That impressive specificity still does not convert a positive result into an IBD diagnosis.

A positive lactoferrin result is especially worth discussing when diarrhoea began abruptly after travel, antibiotics, contaminated food exposure, or contact with someone unwell. In those situations, clinicians usually add pathogen testing rather than jumping straight to an IBD label. Our guide to asil kultur feses covers what a negative or mixed-growth report can and cannot settle.

Cara maca wates tanpa reaksi berlebihan

A calprotectin value below 50 µg/g is usually normal for adults, 50–150 µg/g is often an indeterminate zone, and values above 250 µg/g raise concern for active inflammation. Lactoferrin uses assay-specific cutoffs, commonly a qualitative positive or a quantitative threshold near 7.25 µg/g.

Calprotectin threshold comparison represented by stool assay wells and color gradation
Gambar 4: Quantitative zones help guide retesting and referral decisions.

The 50 µg/g calprotectin threshold is designed for sensitivity: it catches most clinically significant inflammatory disease at the cost of some false positives. The 250 µg/g threshold is more useful for specificity and for monitoring established IBD. Between them lies the frustrating middle, where medication exposure, recent gastroenteritis, age, and trajectory matter more than a single number.

A change from 72 to 94 µg/g is often less meaningful than a change from 85 to 430 µg/g, particularly if both samples were tested by the same laboratory. Stool consistency can influence extraction and biological variation is real. Dr. Thomas Klein’s practical advice is to record NSAID use, recent infection, menstrual contamination, and collection date before interpreting a modest rise.

For a disciplined approach to serial values, compare the sample date with symptoms and related labs rather than treating every flagged result as disease progression. Our pandhuan tren tes getih explains the same principle of reference change and analytic variation in laboratory medicine.

Biasane nguwatirake ora <50 µg/g calprotectin Active colonic IBD is less likely in adults without alarm symptoms.
Zona wates 50–150 µg/g calprotectin Review NSAIDs, infection and symptoms; repeat testing is often appropriate.
Jelas mundhak 150–250 µg/g calprotectin Persistent elevation warrants clinical assessment and often further investigation.
Ndhuwur banget >250 µg/g calprotectin Suggests active mucosal inflammation but still requires cause-specific evaluation.

Yagene tandha loro-duwur tanpa IBD

Elevated stool inflammation markers occur with enteric infection, NSAID exposure, diverticulitis, colorectal neoplasia, microscopic colitis and IBD. The result confirms an inflammatory signal; it does not disclose the cause, location, duration, or severity by itself.

Clinical consultation reviewing anti-inflammatory medication and a stool inflammation report
Gambar 5: Medication history can materially alter interpretation of a raised marker.

Non-steroidal anti-inflammatory drugs can raise fecal calprotectin, sometimes substantially, by increasing intestinal permeability and causing small mucosal injuries. Ibuprofen, naproxen and diclofenac matter; a clinician may suggest withholding them if medically safe before repeating the test. Do not stop prescribed aspirin, anticoagulants, or pain medicines without asking the prescriber first.

Acute bacterial gastroenteritis may produce calprotectin values above 500 µg/g and a positive lactoferrin, which is why a stool pathogen panel can be more informative than an urgent colonoscopy in the first days of illness. Conversely, giardiasis may cause prolonged diarrhoea with less striking neutrophilic marker elevation. The symptom timeline often carries more diagnostic weight than patients expect.

Kantesti iku sawijining layanan interpretasi tes lab AI that can flag an inflammation pattern such as low hemoglobin, low albumin, thrombocytosis and raised CRP for clinician review, but those blood findings do not prove the source is intestinal. For people with blood in the stool, FIT follow-up and colonoscopy timing is a separate issue from calprotectin and should not be delayed.

Kapan asil normal isih bisa ketinggalan penyakit

Normal calprotectin or lactoferrin makes active colonic inflammation less likely, but it cannot fully exclude Crohn’s disease, particularly mild or isolated small-bowel disease. A normal result also does not explain persistent weight loss, iron-deficiency anemia, nocturnal diarrhoea, or recurrent visible bleeding.

Small bowel cross-section showing patchy Crohn's disease activity beyond stool marker reach
Gambar 6: Patchy small-bowel activity may produce a less conspicuous stool signal.

Small-bowel Crohn’s disease can shed less neutrophil protein into a stool sample than extensive colitis, especially when lesions are proximal or mild. This is one reason symptoms and alarm features overrule a reassuring number. The ECCO-ESGAR diagnostic guideline recommends integrating biomarkers with ileocolonoscopy and cross-sectional imaging when IBD remains clinically suspected (Maaser et al., 2019).

A 46-year-old with calprotectin of 38 µg/g, ferritin of 7 ng/mL, and progressive fatigue deserves evaluation for gastrointestinal blood loss or malabsorption even if bowel frequency is normal. In my experience, the combination of iron deficiency and unexplained symptoms is much more consequential than a single low stool marker. Read our low ferritin and gut clues for the usual next laboratory questions.

Celiac disease, bile acid diarrhoea, pancreatic insufficiency and many medication effects may cause symptoms with normal stool inflammation markers. A normal test is therefore a fork in the road toward non-inflammatory diagnoses, not a declaration that symptoms are psychological or unimportant.

Apa sing kudu dilakoni karo asil kalprotektin sing winates

A borderline fecal calprotectin result of 50–150 µg/g is commonly repeated after 2–6 weeks if symptoms are stable and there are no alarm features. The repeat should use the same laboratory method and should be timed away from a recent gastrointestinal infection where possible.

Home stool sample collection kit beside calendar and medication review notes
Gambar 7: A repeat sample is most informative when collection conditions are documented.

Before retesting, clinicians review NSAIDs, proton-pump inhibitors, antibiotics, acute infections, strenuous endurance exercise and age-related risk. There is no universally agreed washout interval for every medicine. A pragmatic plan is often 2 weeks after an acute illness has settled, provided symptoms do not signal a need for earlier care.

If the repeat falls from 118 to 32 µg/g and symptoms settle, invasive testing may be avoidable. If it rises from 96 to 310 µg/g, the direction adds useful evidence even before an endoscopy result arrives. This is why a single borderline value should rarely trigger panic—or false reassurance.

kita borderline calprotectin follow-up guide lays out the questions to bring to a primary-care or gastroenterology appointment. A short symptom diary with stool frequency, nighttime waking, fever and medication dates is usually more useful than obsessively checking food triggers.

Carane dokter nggunakake tandha sawise IBD didiagnosis

In established IBD, calprotectin is most useful for tracking objective intestinal inflammation and helping decide whether symptoms represent a flare, infection, IBS overlap, or treatment failure. Lactoferrin can also follow activity, but calprotectin has more guideline-supported thresholds for treat-to-target monitoring.

Gastroenterology clinic reviewing stool biomarker trend cards alongside blood laboratory results
Gambar 8: Serial biomarkers complement symptoms during IBD follow-up.

Symptoms and mucosal activity frequently diverge. A patient with ulcerative colitis may feel well while calprotectin climbs from 80 to 360 µg/g, or have urgent bowel motions from bile acid malabsorption while calprotectin remains 28 µg/g. The 2023 AGA ulcerative colitis biomarker guideline advises combining symptoms with biomarkers rather than relying on either alone (Singh et al., 2023).

For remission monitoring, many clinicians view less than 150 µg/g as reassuring, while more than 150 µg/g may warrant repeat testing, endoscopy, or treatment review depending on symptoms and prior disease behaviour. In active symptomatic ulcerative colitis, more than 250 µg/g supports ongoing inflammation. Cutoffs are guides, not instructions to alter biologic treatment without specialist input.

Kantesti AI minangka platform interpretasi biomarker AI that organizes blood-test trends around a patient’s reported treatment dates; it cannot assess stool endoscopic severity from a number alone. Patients taking biologics should also understand which blood safety tests monitor treatment and which symptoms require prompt contact with their IBD team.

Carane kesalahan koleksi lan wektu mengaruhi asil

Collection quality affects stool marker interpretation because a contaminated, delayed, or poorly sampled specimen can be rejected or produce a less reliable measurement. Most laboratories want a small stool portion placed into the supplied sterile container without toilet water or urine.

Hands placing stool sample into a sterile collection container using a clinical kit
Gambar 9: Clean collection reduces preventable sample rejection and ambiguity.

Loose stool is usually acceptable for calprotectin and lactoferrin testing; do not wait for a formed sample if diarrhoea is the clinical problem. Avoid collecting from toilet water, and tell the laboratory if the sample includes visible menstrual blood. Storage instructions vary by kit, but many allow short room-temperature transport because calprotectin is comparatively stable.

Sampling a day after a marathon, a bout of gastroenteritis, or colonoscopy bowel preparation may answer the wrong question. Endurance exercise can transiently increase gut permeability and provoke gastrointestinal symptoms. If you are an endurance athlete without red flags, consider timing collection away from a major event; our pandhuan lab kanggo atlet daya tahan explains why context changes test interpretation.

The thing is, a perfect collection does not make a nonspecific biomarker specific. A high-quality sample improves confidence in the measurement; it cannot replace the clinical history, examination, and differential diagnosis.

Tes getih endi sing ndadekake tandha tinja luwih migunani

A CBC, CRP, ferritin, albumin, kidney function and celiac serology often add more clinical value to a raised stool marker than ordering a second stool inflammation protein. The concerning pattern is not any one abnormality but several results that point toward inflammation, malabsorption, or blood loss.

Laboratory blood panel results arranged with a calprotectin stool marker report
Gambar 10: Blood markers add systemic context to an intestinal inflammation result.

Low hemoglobin, ferritin below 15 ng/mL, albumin below the laboratory reference range, raised platelets, or raised CRP can strengthen concern for clinically meaningful bowel disease. None is diagnostic of IBD. In fact, CRP may remain normal in mild ulcerative colitis, and ferritin can look falsely normal when inflammation raises it as an acute-phase protein.

Kantesti iku sawijining Piranti analisis tes getih berbasis AI that reads a CBC, iron studies and CRP in the same clinical frame, including whether a changing hemoglobin level might justify earlier review. Dr. Thomas Klein routinely cautions that an isolated CRP of 12 mg/L is nonspecific, whereas CRP 12 mg/L plus falling albumin and a calprotectin of 740 µg/g is a much more actionable cluster.

For patients whose iron values seem contradictory, our iron studies research guide explains transferrin saturation and ferritin during inflammation. A CBC result guide can also help you identify whether anemia is microcytic, inflammatory, or mixed.

Kapan pesen loro tes bisa masuk akal

Ordering calprotectin and lactoferrin together is usually unnecessary, but it can be reasonable when a specialist is reconciling discordant symptoms, a prior assay cannot be repeated, or a local pathway requires confirmation. Concordant results modestly increase confidence in an inflammatory signal; discordant results usually trigger review, not arithmetic averaging.

Two separate stool inflammation assay cartridges compared in a gastroenterology laboratory
Gambar 11: Different assay platforms should not be treated as interchangeable trend points.

A high calprotectin with negative lactoferrin may reflect assay timing, a result near the cutoff, specimen heterogeneity, or analytical differences. A low calprotectin with positive lactoferrin deserves the same disciplined response: verify collection, review the exact assay, check symptoms and test for infection when appropriate. Neither combination has a validated shortcut to diagnosis.

Dual testing can also be useful in research settings where a protocol prespecifies both biomarkers. That is different from routine patient care, where duplicate testing can add cost without improving decisions. Ask the ordering clinician a simple question: “What will we do differently if the second test is positive?”

If a report looks internally inconsistent, use our pituduh tes kualitatif versus kuantitatif to understand why “positive” and “high” are not interchangeable laboratory statements. Consistency of method matters more than collecting every available marker.

Apa sing bener-bener konfirmasi utawa ngilangi IBD

IBD is diagnosed through a synthesis of symptoms, ileocolonoscopy with tissue sampling, histology, laboratory tests, and sometimes MRI or CT enterography—not from calprotectin or lactoferrin alone. Stool markers help decide who needs these investigations and whether inflammation may be changing over time.

Ileocolonoscopy pathway represented by colon anatomy and clinical diagnostic instruments
Gambar 12: Endoscopy and tissue examination establish the diagnosis beyond biomarker screening.

Colonoscopy allows direct assessment of the terminal ileum and colon and permits tissue examination for chronic inflammatory features, infection, microscopic colitis, dysplasia, and other causes. Imaging is particularly valuable when Crohn’s disease may involve small bowel beyond the reach of a standard colonoscopy. A stool marker is a triage signal, not a microscopic diagnosis.

Do not confuse a fecal immunochemical test with either inflammatory marker. FIT detects human hemoglobin and is used primarily in colorectal cancer screening or lower-GI bleeding pathways, whereas calprotectin and lactoferrin detect neutrophil products. Our comparison of FIT and FOBT explains why a negative inflammation marker does not substitute for recommended cancer screening.

As of September 4, 2026, no major gastroenterology guideline recommends diagnosing Crohn’s disease or ulcerative colitis from a single stool biomarker threshold. That restraint protects patients from both missed disease and unnecessary lifelong diagnostic labels.

Gejala sing ngluwihi asil tes tinja apa wae

Persistent visible rectal bleeding, black tarry stool, severe abdominal pain, fever, fainting, dehydration, rapidly worsening weakness, or unintended weight loss need timely medical assessment regardless of calprotectin or lactoferrin. A normal result should never be used to wait out a potentially urgent symptom pattern.

Patient symptom diary and urgent clinical assessment pathway in a calm medical setting
Gambar 13: Alarm symptoms require clinical triage even when a stool marker is low.

The urgent concern is physiology, not the label on a laboratory report. Frequent watery diarrhoea can produce low potassium, acute kidney injury, and orthostatic symptoms before an inflammation marker returns. Adults with inability to keep fluids down, confusion, fainting, or minimal urine output should seek urgent care.

New bowel symptoms after age 50, a strong family history of colorectal cancer, and iron-deficiency anemia alter the threshold for colon evaluation even when calprotectin is low. A stool marker does not assess cancer risk comprehensively. Our mucus in stool red-flag guide distinguishes common benign patterns from symptoms that need examination.

Children, pregnant people, older adults, and people using immune-suppressing medicines need individualized triage because their baseline risks differ. If you are unsure whether symptoms are urgent, contacting a local clinician or urgent-care service is safer than trying to interpret a number in isolation.

Obrolan praktis sing kudu ditindakake sawise asil sampeyan

The most useful follow-up question is: “Does this result change my need for infection testing, repeat testing, imaging, or endoscopy?” Bringing the exact value, assay name, symptom timeline, medicines, and previous results makes that conversation faster and more clinically precise.

Over-shoulder clinical discussion of stool inflammation results and symptom timeline
Gambar 14: A structured symptom and medication history turns a biomarker into a decision.

Bring a list of the previous 14 days: stool frequency, overnight symptoms, fever, weight change, travel, antibiotics, NSAIDs, and family history. A calprotectin of 180 µg/g after a 3-day febrile diarrhoeal illness calls for a different plan than the same result after 4 months of nocturnal diarrhoea and weight loss.

Kantesti AI can help you organize accompanying blood reports before an appointment, but diagnosis and treatment decisions belong with the clinician who can examine you and arrange definitive testing. Our pendekatan validasi medis kita explains how clinical oversight and source checking are built into responsible laboratory interpretation.

For complex cases, ask who will own the follow-up and when you should expect a repeat result or referral decision. The clinicians on our Dewan Penasehat Medis emphasize that a documented plan beats a vague instruction to “recheck later,” especially when inflammation markers and anemia move in the same direction.

Pesen sing fokus ing keputusan

Choose calprotectin first in most settings, use lactoferrin when it is your service’s validated alternative, and do not assume either result diagnoses IBD. A low result shifts attention toward functional and non-inflammatory causes, while a persistently high result identifies people who may need infection testing, specialist review, or endoscopy.

For uncomplicated chronic diarrhoea, one normal marker—calprotectin below 50 µg/g or a negative lactoferrin according to that laboratory—can reduce the likelihood of active inflammatory disease. For a value above 250 µg/g or a positive lactoferrin with persistent symptoms, the next question is cause, not certainty. Infection, medicine exposure, IBD, and other inflammatory conditions remain on the list.

Most patients find the ambiguity hardest in the 50–150 µg/g calprotectin zone. In my experience, the best next step is usually a carefully timed repeat, not a dietary cleanse, self-directed steroid use, or an internet diagnosis. Keep the same laboratory where feasible so the trend is interpretable.

Kantesti’s pituduh teknologi AI describes how our systems preserve laboratory context while highlighting questions for medical review. The safe use of any AI interpretation is the same here: use it to prepare for a better clinical conversation, never to override red flags or replace diagnostic care.

Pitakonan sing Sering Ditakoni

Punapa calprotectin langkung sae tinimbang lactoferrin kanggé mendeteksi IBD?

Calprotectin biasane luwih disenengi kanggo dugaan IBD amarga umum kasedhiya minangka tes kuantitatif lan nduweni ambang pemantauan sing umum digunakake kayata kurang saka 50 µg/g lan luwih saka 250 µg/g. Laktoperin uga minangka penanda bangku sing asalé saka neutrofil lan bisa lumaku kanthi apik nalika laboratorium nggunakake uji sing wis divalidasi. Ora ana penanda sing ngeselake IBD, amarga infeksi, NSAID, diverticulitis lan kondisi usus liyane bisa nambah loro-lorone. Tes sing luwih apik biasane sing bisa diinterpretasikake dening dokter sampeyan bebarengan karo gejala lan bola-bali nggunakake metode laboratorium sing padha.

Pinten tingkat calprotectin ingkang ngajrihi?

Tingkat kalprotektin feses ing ngisor 50 µg/g umume njaminake kanggo wong diwasa tanpa gejala alangan, dene 50–150 µg/g kerep dianggep wates lan bisa diulang sawise 2–6 minggu. Nilai luwih saka 150–250 µg/g luwih nguwatirake kanggo peradangan usus, lan tingkat luwih saka 250 µg/g biasane nyebabake tinjauan klinis utawa tes luwih lanjut. Tindakan sing tepat gumantung saka assay, gejala, umur, panggunaan NSAID lan apa nilai kasebut mundhak. Nilai 600 µg/g sawise diare bakteri akut bisa duwe makna sing beda tinimbang 600 µg/g sajrone pirang-pirang wulan gejala kronis.

Apa IBS bisa nyebabake calprotectin utawa laktoperin sing dhuwur?

IBS tanpa komplikasi biasane ora nyebabake calprotectin utawa laktiferin feses sing dhuwur amarga IBS ora ngasilake inflamasi usus sing didorong dening neutrofil. Kenaikan calprotectin sing entheng antarane 50 lan 150 µg/g bisa kedadeyan amarga infeksi bubar, panggunaan NSAID, faktor sing gegandhengan karo umur, utawa variasi tes, mula ora otomatis ngilangi IBS. Laktiferin positif utawa calprotectin luwih saka 250 µg/g kudu ndadekake evaluasi kanggo sabab inflamasi utawa infeksi tinimbang nganggep IBS. IBS lan IBD bisa ana bebarengan, sing dadi alesan liyane gejala lan tren iku penting.

Can a normal calprotectin rule out Crohn's disease?

Asil calprotectin normal nyudaake kamungkinan IBD usus gedhe sing aktif nanging ora bisa ngilangi penyakit Crohn kanthi total, utamane penyakit Crohn usus alus sing entheng utawa terisolasi. Nilai ing ngisor 50 µg/g ora kudu ngalahake fitur peringatan kayata anemia defisiensi zat besi, mundhut bobot, diare nokturnal, getihen sing terus-terusan utawa riwayat kulawarga sing kuwat. Clinicians bisa nggunakake ileocolonoscopy, MR enterography utawa evaluasi kapsul nalika curiga klinis tetep dhuwur. Asil paling apik dianggep minangka siji bukti sing nyetel probabilitas tinimbang tes pengecualian pungkasan.

Apa aku kudu mbaleni asil kalprotektin sing ing wates?

Asil calprotectin sing winates 50–150 µg/g asring diambali sawise 2–6 minggu nalika gejala stabil lan ora ana pratandha bebaya. Sadurunge ngulang, klinisi umume mriksa gastroenteritis anyar, panggunaan NSAID, antibiotik lan kahanan koleksi, amarga saben bisa mengaruhi nilai. Gunakake laboratorium sing padha yen bisa, amarga asil saka cara sing beda bisa uga ora bisa dibandhingake langsung. Asil sing munggah menyang utawa ndhuwur 250 µg/g umume luwih bobot klinis tinimbang elevasi tingkat rendah sing stabil.

Apa antibiotik bisa mengaruhi feses calprotectin lan laktoferrin?

Antibiotik bisa mengaruhi panandha radhang usus kanthi ora langsung kanthi nambani, nyebabake, utawa kedadeyan bebarengan karo diare infeksi lan kanthi ngowahi mikrobioma usus. Wong sing ngalami diare sing ana gandhengane karo antibiotik kudu dipeksa kanggo panyebab kaya ta Clostridioides difficile tinimbang napsirake calprotectin sing mundhak utawa lactoferrin positif minangka IBD. Ora ana nomer dina sing bisa dipercaya kanggo ngenteni sawise antibiotik sadurunge dites; wektu gumantung saka gejala lan pitakonan klinis. Diare sing terus-terusan, demam, utawa nyeri weteng sawise antibiotik mbutuhake tes sing dipimpin dening klinisi tinimbang ngobati awake dhewe.

Entuk Analisis Tes Getih Berbasis AI Dina Iki

Gabung karo luwih saka 2 yuta pangguna ing saindenging jagad sing percaya Kantesti kanggo analisis tes lab sing instan lan akurat. Unggah asil tes getihmu lan tampa interpretasi lengkap saka 15,000+ biomarker sajrone sawetara detik.

📚 Publikasi Riset sing Dirujuk

1

Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti LTD. (2026). Urobilinogen ing Tes Urin: Pandhuan Urinalisis Lengkap 2026. Zenodo.. Riset Medis AI Kantesti.

2

Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti LTD. (2026). Iron Studies Guide: TIBC, Iron Saturation & Binding Capacity. Zenodo.. Riset Medis AI Kantesti.

📖 Referensi Medis Eksternal

3

Smalley W et al. (2019). AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults. Gastroenterology.

4

Maaser C et al. (2019). ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications. Journal of Crohn's and Colitis.

5

Singh S et al. (2023). AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis. Gastroenterology.

2M+Tes Analisa
127+negara-negara
75+Basa

⚕️ Penafian Medis

Sinyal Kepercayaan E-E-A-T

Pengalaman

Tinjauan klinis sing dipimpin dokter babagan alur kerja interpretasi lab.

📋

Keahlian

Fokus kedokteran laboratorium babagan carane biomarker tumindak ing konteks klinis.

👤

Kewibawaan

Ditulis dening Dr. Thomas Klein kanthi ditinjau dening Dr. Sarah Mitchell lan Prof. Dr. Hans Weber.

🛡️

Kapercayan

Interpretasi adhedhasar bukti kanthi tindak lanjut sing cetha kanggo nyuda rasa kaget.

🏢 Kantesti LTD Didaftar ing Inggris & Wales · Nomer Perusahaan. 17090423 London, Inggris Raya · kantesti.net
blank
Miturut Prof. Dr. Thomas Klein

Dr. Thomas Klein minangka ahli hematologi klinis sing wis tersertifikasi dewan, dadi Chief Medical Officer ing Kantesti AI. Kanthi pengalaman luwih saka 15 taun ing bidang kedokteran laboratorium lan nduwèni minat gedhé marang interpretasi asil tes getih sing didhukung AI, dhèwèké ngupaya nyambungake teknologi anyar karo praktik klinis saben dina. Bidang sing dadi minaté kalebu analisis biomarker, riset clinical decision support, lan optimalisasi rentang rujukan sing spesifik kanggo populasi. Minangka CMO, dhèwèké nyumbang masukan klinis kanggo benchmarking internal platform lan menehi pengawasan klinis kanggo mutu medis saka laporan pendhidhikan Kantesti.

Maringi Balesan

Alamat email Sampéyan ora dijedulne utāwā dikatonke. Ros sing kudu diisi ānā tandané *